CD163 and plasma cell myeloma: CD163-expressing TAMs displayed elevated levels of pSTAT3 and correlated to poor prognosis in 77 patients with myeloma from STAT3 is over-activated within CD163pos bone marrow macrophages in both Multiple Myeloma and the benign pre-condition MGUS (60).